4th Quarter - Report

PHLOW CORPORATION for PHLOW CORPORATION

Period 4th Quarter 2025 Filed Jan 20, 2026 Signed by Valerie Jewett

Official filing
Firm
PHLOW CORPORATION
Client
PHLOW CORPORATION
Income
—
Expenses
$410,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587); FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)

LobbyistCovered position, as disclosed
JOHN FUNDERBURK —
VALERIE HARDIN JEWETT —

Contacted: Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Office of Management & Budget (OMB); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2572 (119th), S. 4638 (119th), S. 2296 (119th), H.R. 4016 (119th), S. 2587 (119th), H.R. 5304 (119th)

Health Issues HCR

Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)

LobbyistCovered position, as disclosed
JOHN FUNDERBURK —
VALERIE HARDIN JEWETT —

Contacted: Natl Security Council (NSC); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 2062 (119th), S. 1784 (119th), H.R. 3966 (119th)

Manufacturing MAN

Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)

LobbyistCovered position, as disclosed
JOHN FUNDERBURK —
VALERIE HARDIN JEWETT —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Defense, Dept of (DOD)

Bills named: H.R. 3966 (119th), S. 2062 (119th), S. 1784 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.